Patients with hematologic cancer and their caregivers are at risk of financial toxicity, especially in the bone marrow transplantation setting.
News
COVID-19 often disrupts chemotherapy in pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, data suggest.
Active music engagement proved to be a developmentally appropriate and effective coping mechanism for parents and their child with cancer.
Prophylaxis with tixagevimab and cilgavimab (Evusheld) reduced the risk of breakthrough SARS-CoV-2 infections and the severity of COVID-19 among patients with hematologic cancers in an Italian study.
This study compared the quality of content in YouTube videos on chemotherapy for pediatric patients from independent users with that of videos from official health institutions.
The updates were prompted by findings from an investigation of reports describing mature T-cell malignancies among patients treated with these therapies.
Adding cyclophosphamide to pomalidomide and dexamethasone improves PFS in Asian patients with relapsed/refractory multiple myeloma, a phase 3 study suggests.
Researchers sought to determine the safety and efficacy of emapalumab as treatment and prophylaxis of graft failure in post-HSCT patients.
A secondary analysis of supportive care trial data demonstrated that an approach-oriented coping strategy improved QOL and psychological distress in patients with hematologic cancer undergoing HCT.
Researchers sought to determine which geriatric assessment tools were optimal for predicting chemotherapy toxicity events in older patients with advanced lymphoma.